Paciente en hemodiálisis que desarrolla mieloma múltipe, tratada con autotrasplante de médula ósea
Citas
Attal M, Moreau P, Avet-Loiseau H, Harousseau JL. Stem cell transplantation in multiple myeloma. Hematology Am Soc Hematol Educ Program. 2007:311-6.
Badros A, Barlogie B, Siegel E, Roberts J, Langmaid C, Zangari M, et al. Results of autologous stem cell transplant in multiple myeloma patients with renal failure. Br J Haematol. 2001;114(4):822-9.
Dimopoulos MA, Terpos E. Renal insufficiency and failure. Hematology Am Soc Hematol Educ Program. 2010;2010:431-6.
Dimopoulos MA, Terpos E, Chanan-Khan A, Leung N, Ludwig H, Jagannath S, et al. Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group. J Clin Oncol. 2010;28(33):4976-84.
Imrie K, Rumble RB, Crump M. Stem cell transplantation in adults. Recommendation Report [Internet]. Cancer Care Ontario Program in Evidence-based Care, 2009. 79 p. Disponible en: https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=35448 [Consulta sept. 2013]
Spitzer TR, Sykes M, Tolkoff-Rubin N, Kawai T, McAfee SL, Dey BR, et al. Long-term follow-up of recipients of combined human leukocyte antigen-matched bone marrow and kidney transplantation for multiple myeloma with end-stage renal disease. Transplantation. 2011;91(6):672-6.
Tsakiris DJ, Stel VS, Finne P, Fraser E, Heaf J, De Meester J, et al. Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: an ERA-EDTA Registry study. Nephrol Dial Transplant. 2010;25(4):1200-6.
